Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4648559
Max Phase: Preclinical
Molecular Formula: C25H29Cl3FN5O3S2
Molecular Weight: 564.11
Molecule Type: Unknown
Associated Items:
ID: ALA4648559
Max Phase: Preclinical
Molecular Formula: C25H29Cl3FN5O3S2
Molecular Weight: 564.11
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H]1CCCN1Cc1sc(NC(=O)c2cnc(N3CCC(C(=O)O)CC3)c(F)c2)nc1-c1cc(Cl)cs1.Cl.Cl
Standard InChI: InChI=1S/C25H27ClFN5O3S2.2ClH/c1-14-3-2-6-32(14)12-20-21(19-10-17(26)13-36-19)29-25(37-20)30-23(33)16-9-18(27)22(28-11-16)31-7-4-15(5-8-31)24(34)35;;/h9-11,13-15H,2-8,12H2,1H3,(H,34,35)(H,29,30,33);2*1H/t14-;;/m1../s1
Standard InChI Key: HOTWUVFBZXCTHE-FMOMHUKBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 564.11 | Molecular Weight (Monoisotopic): 563.1228 | AlogP: 5.60 | #Rotatable Bonds: 7 |
Polar Surface Area: 98.66 | Molecular Species: ACID | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.45 | CX Basic pKa: 7.94 | CX LogP: 2.69 | CX LogD: 2.60 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.39 | Np Likeness Score: -1.84 |
1. Tanaka H, Negoro K, Koike T, Tsukamoto I, Yokoyama K, Maeda J, Inagaki Y, Shimoshige Y, Ino K, Ishizu K, Takahashi T.. (2020) Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor., 28 (13): [PMID:32386953] [10.1016/j.bmc.2020.115531] |
Source(1):